S. Wilk

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.

E. Britta-Mareen Traenckner, Heike L. Pahl, Timothy P. Henkel et al. · The EMBO Journal · 1995 · 1K citations · Full text

Signal Transduction, Molecular Physiology, Signaling Pathway +10

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.

E. Britta-Mareen Traenckner, S. Wilk, Patrick A. Baeuerle · The EMBO Journal · 1994 · 715 citations · Full text

Protein Function, Signal Transduction, Molecular Physiology +9

Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.

J M Griscavage, S. Wilk, Louis J. Ignarro · Proceedings of the National Academy of Sciences · 1996 · 268 citations · Full text

Inos Mrna, Lipid Peroxidation, Immunology +18

Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome.

Cezary Wójcik, D. Schroeter, S. Wilk et al. · PubMed · 1996 · 144 citations

gamma-Glutamyl dopa: a kidney-specific dopamine precursor.

S. Wilk, Haruko Mizoguchi · Journal of Pharmacology and Experimental Therapeutics · 1978 · 117 citations